ATLANTA (PRWEB)
October 31, 2019

Powered by the Metro Atlanta Chamber, ‘Backed by ATL’ announces Trella Health as one of five new middle-market companies added to the program. The Backed by ATL initiative was launched to support scaling middle-market companies, helping to accelerate growth and fuel economic impact across metro Atlanta. The additional four companies chosen this year include CulturaLink, NOW Corp, Revenue Analytics, and The Gathering Spot.

“We recognize that the economic impact of middle-market companies is undeniable. Helping these companies scale and empowering their leaders for future growth directly aligns with our commitment to shaping and driving the next generation of careers, community and culture in Atlanta,” said Hala Moddelmog, MAC’s president and CEO. “These five companies exemplify the diverse landscape of industries in our region that are fueling growth, creating jobs and generating millions in revenue.”

To date, Backed by ATL companies have raised close to $1 billion in capital and created over 3,000 jobs in the region. The addition of the new companies will not only help drive even greater economic impact, but also help continue to reshape the future of metro Atlanta through innovative approaches to technology across industries. Once selected for the program, MAC partners with each company at no cost to develop a customized acceleration plan based on the organization’s growth strategies. Plans may include a wide range of support, including building connections to potential customers and partners, talent recruitment and retention, funding strategies and more. In addition, the program aims to create a collaborative and supportive community of middle-market companies that together will fuel economic impact throughout the region.

“We are beyond excited to have access to all the phenomenal resources Backed by ATL brings to mid-market companies like ours,” said Ian Juliano, CEO of Trella Health. “It is an honor to be selected.”

Backed by ATL launched in September 2017. Other participating companies include Ally Commerce, First Performance, MaxEx, Nolan Transportation Group, Patientco, Pindrop, PrimeRevenue, QGenda, Rubicon Global, SalesLoft, Skillshot, Springbot, Terminus, TruRating and Urjanet.

Moddelmog added, “Backed by ATL is a prime example of our next-gen mindset to drive the region’s economy and position metro Atlanta as a top-tier global competitor.”

For more information, visit http://www.backedbyatl.com

About Trella Health

Trella Health provides acute, ambulatory, and post-acute organizations with the most complete picture of care activity in their service areas. As one of only a few companies in the country deemed ‘Innovators’ under the Center for Medicare and Medicaid Service’s Virtual Research Data Center Program, Trella has access to 100% of Medicare Part A and Part B claims data. Trella analyzes 1.25 billion claims annually and presents relevant insights to nearly 10,000 users so they can build higher-performing care networks, serve more patients, and reduce the cost of care. Trella is proud to be a Modern Healthcare top 25 Best Places to Work company for the second year in a row.

About the Metro Atlanta Chamber

The Metro Atlanta Chamber (MAC) serves as a catalyst for a more prosperous and vibrant region. To advance economic growth and improve metro Atlanta’s quality of place, MAC is focused on starting, growing and recruiting companies to the 29-county metro Atlanta region. The Chamber is also focused on expanding the region’s innovation economy by promoting and strengthening connections to drive Atlanta’s innovation and entrepreneurial culture. MAC is committed to being an active voice for the business community, serving as an advocate for a competitive business climate and promoting Atlanta’s story. For more information, visit http://www.MetroAtlantaChamber.com.

Share article on social media or email:

ALTAMONTE SPRINGS, Fla. (PRWEB)
October 31, 2019

A recent survey of specialty pharmacies conducted by Zitter Health Insights awarded the #1 patient satisfaction ranking to BioPlus Specialty Pharmacy (BioPlus) among independent specialty pharmacies.

BioPlus scored the highest of the top 12 surveyed independent specialty pharmacies in Zitter’s Specialty Pharmacy Patient Satisfaction Survey (Quarter 2, 2019). This ranking was based on a metric known as the ‘Net Promoter Score ™’ (NPS). NPS measures consumer loyalty and is considered an unbiased benchmark for patient loyalty.

“Our mission is to make the patient experience fast and easy. Therefore, we take NPS very seriously. We are pretty proud of our score and continue to strive for patient satisfaction day after day. The 5-point increase from the NPS in the Q1 2019 survey helps us feel good about the work we’re doing,” explains Stephen Vogt, Pharm.D., CEO of BioPlus. This NPS score places BioPlus at the top of the pack, leading some of the most notable specialty pharmacies.

Nobody can say it better than the actual BioPlus patients included in this survey, who shared what they valued from BioPlus, including: “excellent, reliable service. Knowledgeable and professional staff, who are easy to work with. Financial aid provided is especially appreciated.” It’s not surprising, then, that the majority of current BioPlus patients (77%) feel very loyal to BioPlus and would be “very unhappy” if they were forced to change from BioPlus to a different specialty pharmacy.

Nine out of ten BioPlus patients receive their medication refills within just three days – which is 14% greater than the overall industry average. “Sure, this score gives us some bragging rights, however, our greatest satisfaction comes in seeing patients get on therapy quickly and easily. We’re faster than other pharmacies, which stems from our first-of-its-kind 2-hour, 2-day, 2-click promises,” shares Nicholas Maroulis, Pharm.D., Senior Vice President of Pharmacy Services.

Our service model starts with the 2-Hour Patient Acceptance Guarantee™, which ensures notification to physician offices in less than two hours whether a referred patient is accepted for treatment or not. After that, prescriptions move though our 2-Day Ready 2 Ship™ process. Throughout every step, our copay assistance team helps ensure that financial hardships don’t stand in the way of patient treatment. And, it takes patients only 2-clicks to refill their qualifying prescriptions online.

Zitter Health Insights Specialty Pharmacy Patient Satisfaction Survey covers the time period of Quarter 2, 2019 and was based on 4,000 patients in at least 10 therapeutic areas at the top 12 specialty pharmacies.

If you are a healthcare provider who wants your patients to receive the highest level of patient satisfaction during their medication therapy, refer your patients to BioPlus.

About BioPlus Specialty Pharmacy

Meet the first and only independent, national specialty pharmacy to back up the promise of ‘fast and easy’ with a 2-Hour, 2-Day, and 2-Click promise. The 2-Hour Patient Acceptance Guarantee™ ensures notification to physician offices in less than two hours whether a referred patient is accepted for treatment or not. Then, prescriptions move through the 2-Day Ready 2 Ship™ process. For qualifying prescriptions, medication refills are only 2-clicks away. It’s the Power of 2.

Ranked #1 by both patients and prescribers, BioPlus provides a complete range of specialty pharmacy services for cancer, multiple sclerosis, hepatitis C, and other complex, chronic conditions. BioPlus, Where Healing Begins in 2 Hours™.

For information: http://www.bioplusrx.com or

Contact: info@bioplusrx.com

Phone: 1-888-292-0744

Share article on social media or email:

HERNDON, Va. (PRWEB)
October 31, 2019

Liberty IT Solutions LLC, which specializes in Health Information Technology has been awarded their largest award to date with the 60-month (1-year base period, plus 4 option years) Health Integration and Modernization (HI&M) Task Order from the Department of Veterans Affairs (VA). This $434M Task Order will consolidate the Enterprise Portfolio Management Division (EPMD) Health Portfolio’s application under one modernization effort. This will allow VA to institute leading development practices to benefit all applications. Liberty will partner with Geek Sources Inc. and Ad Hoc LLC on the HI&M Task Order, both bringing unique experience and expertise to the program.

Through the modernization effort, Liberty will consolidate Office of Information and Technology (OIT) EPMD Health Portfolio projects and products into the Cerner Electronic Health Record (EHR) system. This will require Liberty to create a System of Systems (SoS) that supports Cerner and the Health Portfolio.

Liberty CEO, Bill Greene, says of the win: “Liberty is honored to take on the Health Integration and Modernization Task Order. Our abilities, along with those of our partners, will prove to be a successful match for delivering a high-quality product to Veterans Affairs. The modernization of the EPMD Health Portfolio’s applications is an exciting opportunity for Liberty, and we look forward to our partnership with VA on this important Task Order.”

Under this Task Order, Liberty and partners will deliver Human-Centered Design (HCD) and Application Performance Monitoring (APM) at scale to inform opportunities to deliver Veteran-centric products that preemptively resolve practical issues users face by developing user-focused products. This robust APM solution will inform developers and VA staff about issues before they impact the Veterans/users.

Share article on social media or email:

BASEL, Switzerland (PRWEB)
October 31, 2019

As part of the partnership, PPC will use the Patient Network Explorer platform to advance clinical trials, trial enrollment, and accelerate global studies conducted in the People’s Republic of China, the Republic of China (Taiwan) and the Republic of Korea (South Korea). PPC will encourage hospitals to participate in Clinerion’s Patient Network Explorer platform for generation of RWD/RWE and bringing more global studies to hospitals.

PPC provides a fully integrated solution for Phase I-IV studies in Asian countries. PPC is dedicated to serve the pharmaceutical and biotechnology industry with world-class quality and cost-effective solutions to shorten the lead time to market. PPC provides full services for clinical trials, such as Project Management, Regulatory Affairs, Clinical Monitoring, Biostatistics, Data Management, Medical Writing, and Pharmacovigilance.

Patient Network Explorer supports patient health by matching patients from Clinerion’s global network of hospitals to clinical trials conducted by pharmaceutical sponsors or researchers performing academic investigations. The system is based on de-identified EHR data, unlinked from any identifiers, protecting patient privacy. The partners’ combined services will accelerate access for patients and hospitals to next-generation medical treatments. Patients in the region will become more visible to sponsors for trial recruitment, and hospitals in the region will become better placed to run clinical trials, ultimately accelerating drug launch.

“We are excited to be partnering with Clinerion to jointly offer our customers access to global integrated recruitment services through the Patient Network Explorer platform,” says Michael Stibilj, CEO of PPC. “This relationship will enable researchers and hospitals, in our region, to have additional opportunities to be involved in global trials, also providing patients access to new potential treatments. Increased access to patients will speed up the clinical trial process and help accelerate the development of break-through products.”

“The strength of Patient Network Explorer lies in its global coverage,” says Ian Rentsch, Clinerion CEO. “Clinerion’s hospital network currently covers 19 countries and over 73 M patients. The partnership with PPC promises to deepen our presence in Korea and Taiwan, and expand our coverage to China. Clinerion continues to build our global presence!”

About Clinerion

Clinerion accelerates clinical research and medical access to treatments for patients. We use proprietary technologies for analysis of patient data from our global network of partner hospitals. Clinerion’s Patient Network Explorer radically improves the efficiency and effectiveness of clinical trial recruitment by offering data-driven protocol optimization, site feasibility evaluation and real-time patient search and identification to match patients to treatments. Our technology solution provides real-world evidence analytics for medical access. Clinerion facilitates the participation of partner hospitals in leading-edge, industry-sponsored trials and time savings in patient recruitment. We create innovative and disruptive fit-for-purpose solutions which enable pharmaceutical companies to shorten patient recruitment and save costs by streamlining operations and leveraging strategic intelligence. Clinerion’s proprietary Big Data analytics technologies leverage real-time data from electronic health records which comply with international patient privacy and data security regulations. Clinerion is a global data technology service company headquartered in Switzerland.

Clinerion website: http://www.clinerion.com

Clinerion’s Patient Network Explorer: http://www.clinerion.com/index/OverviewOurSolutions/ClinerionPatientNetworkExplorer

For more information, please contact:

Le Vin Chin

Director, Head of Marketing & Communications

Clinerion Ltd

Elisabethenanlage 11, 4051 Basel, Switzerland

Tel.: +41 61 865 60 54

media@clinerion.com

About PPC.

PPC group was founded in 1997, provides professional services for clinical studies to pharmaceutical and biotechnology companies. PPC offers clinical and laboratory services in China, Taiwan, Korea and Japan. Since 1997, PPC has completed over 2000 early phase trials including innovative phase I pharmacokinetic, generic bioequivalence and biosimilar studies for local and global pharmaceuticals companies in Asia. In addition, PPC has conducted over 500 innovative phase II- IV trials, covering 24 therapeutic areas. PPC group has 7 offices, 4 phase I units, 3 bioanalytical labs and 1 central lab in China, Taiwan, Korea and Japan, employing over 600 staff.

PPC website: http://www.ppccro.com

For more information, please contact:

Gerard Kim

Business Development Associate

PPC Korea Co., Ltd.

20F, SamWon Tower 124, Teheran-ro, Gangnam-gu, Seoul, Korea, 06234

Tel.: +82 2 2054 0651

Fax: +82 2 535 0511

Mobile: +82 10 5264 4105

junghoon.kim@ppccro.com

Share article on social media or email:

LOS ANGELES (PRWEB)
October 30, 2019

The Haute Beauty Network, well known for its exclusive and luxurious lifestyle publication Haute Living is privileged to present Dr. Neda Shamie as a visual expert and our newest addition to the Haute Beauty members-only network.

Haute Beauty offers a prominent collective of leading doctors. The invitation-only exclusive publication maintains elite as ever, with only two doctors in every market. This partnership allows Haute Beauty to connect its affluent readers with industry-leading aesthetic surgeons located in their area.

Neda Shamie, MD is a renowned LASIK, cataract, and corneal surgeon and partner of the Maloney-Shamie Vision Institute in Los Angeles. She previously was the Medical Director of the Doheny Eye Institute and is a Clinical Professor of Ophthalmology at the USC Keck School of Medicine.

ABOUT DR. NEDA SHAMIE

Dr. Shamie graduated Summa Cum Laude with high honors from UCLA and obtained her medical degree from UCSF School of Medicine. She completed her residency and fellowship training in corneal and laser refractive surgery at UC Irvine where she also served as Director of the Corneal Service. Soon thereafter she joined the Devers Eye Institute in Portland, Oregon, where together with Dr. Mark Terry, they spearheaded many projects and advances in the field of lamellar corneal transplantation with emphasis on endothelial keratoplasty (DSEK and DMEK).

Dr. Shamie was the first surgeon in the Northwest to offer both artificial corneal transplantation and DMEK surgery to her patients. Recognized as an expert in complex vision correction surgery, Dr. Shamie has coauthored over 50 publications on the topics of cataract surgery and corneal transplantation, written 8 chapters for surgical textbooks and has led international lectures, courses, and seminars teaching colleagues about the advances in vision correction surgery. In 2017, the American Academy of Ophthalmology awarded her the Senior Achievement Award for contributions to the education of other eye surgeons. She has trained and instructed over 500 surgeons and has personally performed over 6,500 vision correction surgeries.

She is an active member of numerous ophthalmic societies, has served on the Cornea Clinical Committee of the American Society of Cataract and Refractive Surgery, was the President of the Los Angeles Society of Ophthalmology and has been voted by peers to be among America’s Top Doctors.

Dr. Neda Shamie specializes in advanced vision correction surgery including LASIK, PRK, ICLs, refractive lens exchange, and advanced lens laser cataract surgery. She also is an expert in complex corneal transplant surgeries including DMEK, DSEK, DALK, and PKP as well as the breakthrough, non-invasive keratoconus treatment, Collagen Cross-Linking.

Visit Dr. Shamie’s profile on Haute Beauty: https://hauteliving.com/hautebeauty/member/dr-neda-shamie/

Share article on social media or email:

New skin care system from VitalFitSR for prosthetic users

It is unfortunate that those with limb loss have obstacles to living an active, healthy life, and I’m pleased to play a role in helping them overcome barriers related to skin care issues

SAN DIEGO (PRWEB)
October 30, 2019

VitalFitSR, the first skin care system formulated by Paul B. Dean, M.D. in collaboration with other dermatologists and clinicians to address the skin issues faced by individuals with limb loss and high-risk skin issues, launched this month at the Challenged Athlete Foundation (CAF) Annual Community Weekend event in San Diego, CA.

“We have had an overwhelmingly positive reaction from those in the limb-loss community as a result of this skin-care system,” said Paul B. Dean, M.D., founder of VitalFitSR. “We recognized a need for a clinical system to address the challenges that these individuals face every day. It is unfortunate that those with limb loss have obstacles to living an active, healthy life, and I’m pleased to play a role in helping them overcome barriers related to skin care issues.”

Skin conditions are a leading cause of the inability to comfortably wear prosthetic devices, orthotics or diabetic shoe products. The VitalFitSR system contains a unique blend of ingredients that reduces the potential for inflammation, perspiration, odor, fungal infection, dermatitis, and bacteria. The system also works in conjunction to prevent irritation and dry, chapped skin.

VitalFitSR launched in conjunction with being an official sponsor of the Challenged Athletes Foundation in San Diego. The input from participants solidified VitalFit’s mission to enhance lives and their dedication to the support and education of individuals as well as the clinicians that serve them.

Paul B. Dean, M.D. has been practicing dermatology in San Diego for more than 35 years, and is the founder of a hypo-allergenic, ultra-sensitive line of skincare products called Skin Resource.MD available online and in medical offices.

For more information on VitalFitSR, please go to http://www.vitalfitsr.com.

About VitalFitSR

VitalFitSR is the first dermatologist-formulated and approved skin care system for those experiencing challenges from using prosthetics, orthotics or who have dysvascular/neuropathy. VitalFitSR was started in 2019 by Paul B. Dean, M.D., a board-certified dermatologist and founder of Skin Resource.MD.

Share article on social media or email: